BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 18572443)

  • 1. Vasopressin in septic shock.
    Landry DW; Oliver JA
    N Engl J Med; 2008 Jun; 358(25):2736-7; author reply 2737-8. PubMed ID: 18572443
    [No Abstract]   [Full Text] [Related]  

  • 2. Septic shock--vasopressin, norepinephrine, and urgency.
    Parrillo JE
    N Engl J Med; 2008 Feb; 358(9):954-6. PubMed ID: 18305271
    [No Abstract]   [Full Text] [Related]  

  • 3. Vasopressin in septic shock.
    Dünser MW; Hasibeder WR; Wenzel V
    N Engl J Med; 2008 Jun; 358(25):2736; author reply 2737-8. PubMed ID: 18572442
    [No Abstract]   [Full Text] [Related]  

  • 4. Vasopressin in septic shock.
    Boyle WA; Leone M
    N Engl J Med; 2008 Jun; 358(25):2736; author reply 2737-8. PubMed ID: 18565870
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparison of initial monotherapy with norepinephrine versus vasopressin for resuscitation in septic shock.
    Daley MJ; Lat I; Mieure KD; Jennings HR; Hall JB; Kress JP
    Ann Pharmacother; 2013 Mar; 47(3):301-10. PubMed ID: 23447481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasopressin versus norepinephrine infusion in patients with septic shock.
    Russell JA; Walley KR; Singer J; Gordon AC; Hébert PC; Cooper DJ; Holmes CL; Mehta S; Granton JT; Storms MM; Cook DJ; Presneill JJ; Ayers D;
    N Engl J Med; 2008 Feb; 358(9):877-87. PubMed ID: 18305265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anesthetic management using vasopressin for a patient complicated with septic shock].
    Matsuno Y; Saito K; Hirabayashi Y; Seo N
    Masui; 2006 Nov; 55(11):1398-400. PubMed ID: 17131893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasopressin in septic shock.
    Mogyorosi A
    N Engl J Med; 2008 Jun; 358(25):2737; author reply 2737-8. PubMed ID: 18572444
    [No Abstract]   [Full Text] [Related]  

  • 9. Prospective Open-label Trial of Early Concomitant Vasopressin and Norepinephrine Therapy versus Initial Norepinephrine Monotherapy in Septic Shock.
    Hammond DA; Ficek OA; Painter JT; McCain K; Cullen J; Brotherton AL; Kakkera K; Chopra D; Meena N
    Pharmacotherapy; 2018 May; 38(5):531-538. PubMed ID: 29600824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does body weight impact the efficacy of vasopressin therapy in the management of septic shock?
    Miller JT; Welage LS; Kraft MD; Alaniz C
    J Crit Care; 2012 Jun; 27(3):289-93. PubMed ID: 21855282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Early Vasopressin vs Norepinephrine on Kidney Failure in Patients With Septic Shock: The VANISH Randomized Clinical Trial.
    Gordon AC; Mason AJ; Thirunavukkarasu N; Perkins GD; Cecconi M; Cepkova M; Pogson DG; Aya HD; Anjum A; Frazier GJ; Santhakumaran S; Ashby D; Brett SJ;
    JAMA; 2016 Aug; 316(5):509-18. PubMed ID: 27483065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shock.
    Russell JA; Walley KR; Gordon AC; Cooper DJ; Hébert PC; Singer J; Holmes CL; Mehta S; Granton JT; Storms MM; Cook DJ; Presneill JJ;
    Crit Care Med; 2009 Mar; 37(3):811-8. PubMed ID: 19237882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and Safety of the Early Addition of Vasopressin to Norepinephrine in Septic Shock.
    Hammond DA; Cullen J; Painter JT; McCain K; Clem OA; Brotherton AL; Chopra D; Meena N
    J Intensive Care Med; 2019; 34(11-12):910-916. PubMed ID: 28820036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low dose vasopressin for septic shock: where does it belong in therapy?
    Johnson TJ
    S D J Med; 2004 Jul; 57(7):255-6. PubMed ID: 15332318
    [No Abstract]   [Full Text] [Related]  

  • 15. The Septic Shock 3.0 Definition and Trials: A Vasopressin and Septic Shock Trial Experience.
    Russell JA; Lee T; Singer J; Boyd JH; Walley KR;
    Crit Care Med; 2017 Jun; 45(6):940-948. PubMed ID: 28333757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the discontinuation sequence of norepinephrine and vasopressin on hypotension incidence in patients with septic shock: A meta-analysis.
    Duclos G; Baumstarck K; Dünser M; Zieleskiewicz L; Leone M
    Heart Lung; 2019; 48(6):560-565. PubMed ID: 31126701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating Vasopressor Discontinuation Strategies in Patients With Septic Shock on Concomitant Norepinephrine and Vasopressin Infusions.
    Musallam N; Altshuler D; Merchan C; Zakhary B; Aberle C; Papadopoulos J
    Ann Pharmacother; 2018 Aug; 52(8):733-739. PubMed ID: 29560736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Norepinephrine in septic shock--does the early bird catch the worm?
    Ertmer C; Westphal M; Bone HG
    Crit Care Med; 2007 Jul; 35(7):1794-5. PubMed ID: 17581373
    [No Abstract]   [Full Text] [Related]  

  • 19. Discontinuation of Vasopressin Before Norepinephrine in the Recovery Phase of Septic Shock.
    Hammond DA; McCain K; Painter JT; Clem OA; Cullen J; Brotherton AL; Chopra D; Meena N
    J Intensive Care Med; 2019 Oct; 34(10):805-810. PubMed ID: 28618919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative Effectiveness of Second Vasoactive Agents in Septic Shock Refractory to Norepinephrine.
    Nguyen HB; Lu S; Possagnoli I; Stokes P
    J Intensive Care Med; 2017 Aug; 32(7):451-459. PubMed ID: 27189952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.